Skip to content
Menu

Head-to-head dispatch

Bodi Envi vs VyrarX

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #161
Bodi Envi

Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation.

$179/mo sema · $249/mo tirz · Verified July 25, 2026

Marked down on: Compounded semaglutide and tirzepatide are not FDA-approved finished products

vs
Dispatch #84Desk pick
VyrarX

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, with provider messaging and nutrition coaching included — and no ladder published behind either "from".

From $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") sema · From $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") tirz · Verified August 29, 2026

Marked down on: Both prices are "from" figures with nothing behind them — no ladder, no dose banding, no plan lengths — on a site whose own badge reads "Transparent pricing"

VyrarX takes this head-to-head with the higher Desk Score, 78/100 (C+) against 69/100 (C) for Bodi Envi. Bodi Envi still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Bodi Envi

69/100

C

Overall

VyrarX

78/100

C+

Price transparency

94
78

State access

24
78

Molecule range

66
66

Onboarding speed

79
82

Support responsiveness

86
88

Licensing & trust

68
79

The spec sheet

FieldBodi EnviVyrarX
Semaglutide$179/moFrom $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from")
Tirzepatide$249/moFrom $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from")
CoverageNot listed on Bodi Envi's site (checked July 25, 2026)47 states (not California, South Carolina or New Jersey)
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forTransparent flat-price compounded semaglutide & tirzepatide with no membership fee.Readers outside California, South Carolina and New Jersey who want provider messaging and nutrition coaching bundled in, and will complete a five-minute intake to learn what the price becomes at their dose.
Desk Score69/100C78/100C+

The verdict

Desk pick — VyrarX

VyrarX takes this head-to-head with the higher Desk Score, 78/100 (C+) against 69/100 (C) for Bodi Envi. Bodi Envi still holds its ground where its strengths line up with yours.

Choose Bodi Envi if…

Transparent flat-price compounded semaglutide & tirzepatide with no membership fee.

$179/mo sema · $249/mo tirz

Choose VyrarX if…

Readers outside California, South Carolina and New Jersey who want provider messaging and nutrition coaching bundled in, and will complete a five-minute intake to learn what the price becomes at their dose.

From $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") sema · From $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") tirz · 47 states (not California, South Carolina or New Jersey)

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Bodi Envi · VyrarX.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.